Human Cloning Ban Extended [Russia]
        
            By Moscow Times, 
                Moscow Times
             | 03. 11. 2010
        
                    
                                    
                    
                                                                                                                                    
                                                                            
                              
    
  
  
    
  
          
  
      
    
            The State Duma has renewed a temporary ban on human cloning in Russia, Interfax reported Wednesday.
The bill, approved in a third and final reading Wednesday, sets a ban on cloning until a federal law can be enacted to regulate the cloning of humans, the report said.
The bill allows the cloning of nonhuman cells, like flowers, for scientific purposes.
The previous ban was implemented in 2002 but expired in June 2007.
Deputy Health and Social Development Minister Yury Voronin has warned that the absence of a ban might make Russia a destination for foreign scientists eager to conduct human cloning experiments. 
 
       
 
  
 
    
    
  
   
                        
                                                                                
                 
                                                    
                            
                                  
    
  
  
      Related Articles
    
  
          
  
  
  
  
  
  
      
            
                  
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Emma Belmonte,  ChinaFile | 10.03.2025
                                                        
     
    
    
            
On the popular Chinese social media platform Xiaohongshu, also known as RedNote, an account called “Georgia Notes” (@格鲁吉亚小纸条) offers tips and advice to Chinese nationals planning a trip to the Republic of Georgia. In one post...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Karin Hammarberg, Alex Polyakov, Catherine Mills, and Karinne Ludlow,  The Conversation | 10.03.2025
                                                        
     
    
    
            Reports of several cases of embryo and sperm mix-ups have put the Australian fertility industry in the spotlight for all the wrong reasons.
These bungles have raised serious questions about the industry’s current model of self-regulation, and demonstrate a lack...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Jared Whitlock,  Endpoints News | 10.09.2025
                                                        
     
    
    
            When Nirnay Murthy learned about a treatment for his toddler son’s rare condition, relief quickly gave way to disappointment.
A one-time gene therapy called Zolgensma from the Swiss drugmaker Novartis can halt spinal muscular atrophy, a deadly condition that causes...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Karin Hammarberg and Catherine Mills,  BioNews | 10.13.2025
                                                        
     
    
    
            
The Australian fertility industry has been rocked by several recent cases of embryo and sperm mix-ups. With a lack of transparency about what clinics do to prevent such errors recurring, trust and confidence in the industry and how it is...